The current state of NHS pathology: personal perspectives, Steve Blunden
9.40-10.00
Emerging role of the Biomedical Scientist in diagnostic pathology reporting, Debra Padgett, President Institute of Biomedical Science, Lead healthcare Scientist, Northumbria Healthcare
10.00-10.20
Panel discussion: Steve Blunden, Andrea Gooding, Debra Padgett and moderator
10.25-10.45
Accrediting a Digital pathology service, Asha Velani
10.45-11.15
Tea/coffee
Chair/moderator
Steve Blunden
11.15-11.35
Laboratory readiness for a digital workflow, Andrea Gooding, Specialty General Manager for Cellular Pathology at Nottingham University Hospitals
11.35-11.55
Pathologist readiness for a digital workflow, Runjan Chetty, Chief Medical Officer, Diagnexia
11.55-12.15
AI tools for routine diagnostics, Rob Sykes, Senior Pathology Product Manager, Diagnexia
12.15-13.00
Panel discussion: Steve Blunden, Andrea Gooding, Asha Velani, Runjan Chetty, Rob Sykes
13.00-14.30
Lunch
Chair/moderator
James Johnson, Senior Manager, Technical Integration & Support Diagnexia
14.30-14.55
Biomarkers in cancer diagnostics, Dr Mahomed Dada, Consultant Pathologist at Royal Derby Hospital
14.55-15.20
My approach to reporting endometrial biopsies, Dr Hamid Kazerouni, Deputy Medical Director, Diagnexia
15.20-15.45
How to cut-up and block complex GI specimens, Dr Adam Booth, Assistant Professor, Washington University School of Medicine, St Louis, US
15.45-16.10
Challenges and pitfalls in melanocytic lesions, Dr Mahomed Dada
16.10-16.35
How to handle GU specimens, Dr Pedro Oliveira
16.35-16.50
Panel discussion: James Johnson, Mahomed Dada, Hamid Kazerouni, Adam Booth
16.50-17.45
Tea, demonstration sessions, informal chat
28
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.